Table 1. Epidemiology of gender confirming surgery. A summary of the literature’s description of the prevalence of TGNB identity, as well as GCS overall and specific procedures in specific populations, is given.
| Parameter | Range of estimated prevalence among transgender people in the USA, % (Ref.) |
|---|---|
| TGNB identity* | 0.39–2.7* (1,3-6) |
| GCS overall | 25–35 (7,8) |
| GCS in trans men | 42–54 (7,8) |
| GCS is trans women | 28 (7) |
| GCS in non-binary | 9 (7) |
| Genital surgery | 4–13 (8,9) |
| Trans men | 25–50 (1-3) |
| Hysterectomy | 14 (7) |
| Phalloplasty | 3 (7) |
| Metoidioplasty | 2 (7) |
| Trans women | 5–13 (1-3) |
| Non-binary assigned male at birth | 1 (7) |
| Non-binary assigned female at birth | <1 (7) |
| Hysterectomy in non-binary | 2 (7) |
| Chest/breast surgery | 8–25 (8,9) |
*, estimated percent of total US population. TGNB, transgender and gender non-binary; GCS, gender confirming surgery.